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Obstructive sleep apnea (OSA) is a common disorder characterized by repetitive collapse of the pharynx during sleep, necessitating recurrentawakenings to reestablish upper airway patency. 1 The Wisconsin Sleep Cohort Study evaluated working age adults and estimated an OSA prevalence of 4% among men and 2% among women, using a definition that required both an apnea/hypopnea index (AHI) of = 5 and symptoms of OSA. Employing a broader definition to include an AHI of = 5 with or without symptoms, they observed a prevalence of 9% among women and 24% among men. 2 Prevalence of
Sleep-disordered Breathing in Middle-aged Korean Men
and Women (AHI = 5) was 27% in men and 16% in women. 3 When OSA was defined by an AHI = 5 plus excessive daytime sleepiness, its prevalence was 4.5% in men and 3.2% in women. 3 OSA is considered as a risk factor for cardiovascular and cerebrovascular disorders such as hypertension, congestive heart failure, myocardial infarction, and stroke [4] [5] [6] and is also associated with impaired cognitive function and alertness which contribute to the increased rates of motor vehicle accidents. 7, 8 Because continuous positive airway pressure (CPAP) is extremely effective in eliminating pharyngeal collapse, improves symptoms, and may reduce cardiovascular sequelae, diagnosis and effective treatment of these patients has important individual as well as public health benefits. 9 This review focuses on OSAS treatment with positive airway pressure.
Mechanisms of continuous positive airway pressure
Sullivan and co-worker showed CPAP as a treatment for OSAS in adults in 1981. 10 Pharyngeal airway collapse occurs when intraluminal pressure is less than the pressure required to keep it from closing (i.e., critical closing pressure). CPAP serves to raise intraluminal pressure such that even a very collapsible pharynx (i.e., one with a very positive critical closing pressure) will maintain patency. The risk for hypertension engendered by OSA is increasingly acknowledged but the impact of PAP on hypertension remains controversial. 19, 20 Cheyne-Stoke breathing (CSB) is an independent predictor of mortality from congestive heart failure. CPAP has been shown to eliminate CSB and decrease mortality in patients with thispattern of periodic breathing. 21 OSA has been associ- 
Compliance with CPAP therapy
Despite the potential advantages of nasal CPAP in OSA, discomfort from the facial mask, the air pressure, and nasal symptoms often limit the extent to which patients are willing to use this therapy. Between 4.5% and 50% of patients refuse CPAP after a single night's use in the laboratory and another 20% stop treatment primarily because of lack of benefit. 27 Estimates from various studies suggest that, on average, patients use the treatment only 4 to 5 hours per night. 28 The adverse effects of CPAP have been well recognized (Table 1) . 29 The current practice is to perform CPAP titration in the laboratory with a full polysomnography (PSG). A number of APAP devices are commercially available. They monitor different parameters to detect breathing events and 
